These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 16803899
21. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030. Nguyen NQ, Krishnan NP, Rojas LJ, Prati F, Caselli E, Romagnoli C, Bonomo RA, van den Akker F. Antimicrob Agents Chemother; 2016 Jan 04; 60(3):1760-6. PubMed ID: 26729491 [Abstract] [Full Text] [Related]
22. Role of Asp104 in the SHV beta-lactamase. Bethel CR, Hujer AM, Hujer KM, Thomson JM, Ruszczycky MW, Anderson VE, Pusztai-Carey M, Taracila M, Helfand MS, Bonomo RA. Antimicrob Agents Chemother; 2006 Dec 04; 50(12):4124-31. PubMed ID: 16982784 [Abstract] [Full Text] [Related]
23. Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes. Giakkoupi P, Tzelepi E, Legakis NJ, Tzouvelekis LS. FEMS Microbiol Lett; 1998 Mar 01; 160(1):49-54. PubMed ID: 9495011 [Abstract] [Full Text] [Related]
24. Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface. Reynolds KA, Hanes MS, Thomson JM, Antczak AJ, Berger JM, Bonomo RA, Kirsch JF, Handel TM. J Mol Biol; 2008 Oct 24; 382(5):1265-75. PubMed ID: 18775544 [Abstract] [Full Text] [Related]
25. Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface. Reynolds KA, Thomson JM, Corbett KD, Bethel CR, Berger JM, Kirsch JF, Bonomo RA, Handel TM. J Biol Chem; 2006 Sep 08; 281(36):26745-53. PubMed ID: 16809340 [Abstract] [Full Text] [Related]
26. Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study. Baig MH, Sudhakar DR, Kalaiarasan P, Subbarao N, Wadhawa G, Lohani M, Khan MK, Khan AU. PLoS One; 2014 Sep 08; 9(12):e112456. PubMed ID: 25479359 [Abstract] [Full Text] [Related]
27. Site-saturation mutagenesis of position V117 in OXA-1 β-lactamase: effect of side chain polarity on enzyme carboxylation and substrate turnover. Buchman JS, Schneider KD, Lloyd AR, Pavlish SL, Leonard DA. Biochemistry; 2012 Apr 10; 51(14):3143-50. PubMed ID: 22429123 [Abstract] [Full Text] [Related]
28. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam. Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA. Antimicrob Agents Chemother; 2015 Jul 10; 59(7):3710-7. PubMed ID: 25666153 [Abstract] [Full Text] [Related]
29. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Lemozy J, Sirot D, Chanal C, Huc C, Labia R, Dabernat H, Sirot J. Antimicrob Agents Chemother; 1995 Nov 10; 39(11):2580-2. PubMed ID: 8585751 [Abstract] [Full Text] [Related]
31. Elucidating the role of Trp105 in the KPC-2 β-lactamase. Papp-Wallace KM, Taracila M, Wallace CJ, Hujer KM, Bethel CR, Hornick JM, Bonomo RA. Protein Sci; 2010 Sep 10; 19(9):1714-27. PubMed ID: 20662006 [Abstract] [Full Text] [Related]